212 related articles for article (PubMed ID: 9853398)
1. A wild-type Japanese measles virus strain inducing predominant early down-regulation of CD46.
Sakata H; Kurita M; Murakami Y; Nagasawa S; Watanabe M; Ueda S; Matsumoto M; Sato T; Kobune F; Seya T
Biol Pharm Bull; 1998 Nov; 21(11):1121-7. PubMed ID: 9853398
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.
Murakami Y; Seya T; Kurita M; Fukui A; Ueda S; Nagasawa S
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1351-9. PubMed ID: 9494106
[TBL] [Abstract][Full Text] [Related]
3. Effect of mutations at the residues R25, D27, P69, and N70 of B95a-MCP on receptor activities for the measles viruses Nagahata wild-type strain and CAM vaccine strain.
Murakami Y; Fukui A; Seya T; Ueda S; Nagasawa S
Int J Mol Med; 1999 Jan; 3(1):25-32. PubMed ID: 9864382
[TBL] [Abstract][Full Text] [Related]
4. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.
Manchester M; Liszewski MK; Atkinson JP; Oldstone MB
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2161-5. PubMed ID: 8134365
[TBL] [Abstract][Full Text] [Related]
5. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46.
Kurita-Taniguchi M; Fukui A; Hazeki K; Hirano A; Tsuji S; Matsumoto M; Watanabe M; Ueda S; Seya T
J Immunol; 2000 Nov; 165(9):5143-52. PubMed ID: 11046046
[TBL] [Abstract][Full Text] [Related]
6. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of wild-type measles virus to CD46 receptor usage.
Nielsen L; Blixenkrone-Møller M; Thylstrup M; Hansen NJ; Bolt G
Arch Virol; 2001; 146(2):197-208. PubMed ID: 11315632
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of measles virus entry and dissemination through different receptors.
Schneider U; von Messling V; Devaux P; Cattaneo R
J Virol; 2002 Aug; 76(15):7460-7. PubMed ID: 12097558
[TBL] [Abstract][Full Text] [Related]
9. Differential receptor usage by measles virus strains.
Bartz R; Firsching R; Rima B; ter Meulen V; Schneider-Schaulies J
J Gen Virol; 1998 May; 79 ( Pt 5)():1015-25. PubMed ID: 9603316
[TBL] [Abstract][Full Text] [Related]
10. The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium.
Seya T; Kurita M; Iwata K; Yanagi Y; Tanaka K; Shida K; Hatanaka M; Matsumoto M; Jun S; Hirano A; Ueda S; Nagasawa S
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):135-44. PubMed ID: 9078253
[TBL] [Abstract][Full Text] [Related]
11. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells.
Schneider-Schaulies J; Schnorr JJ; Schlender J; Dunster LM; Schneider-Schaulies S; ter Meulen V
J Virol; 1996 Jan; 70(1):255-63. PubMed ID: 8523534
[TBL] [Abstract][Full Text] [Related]
12. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains.
Lecouturier V; Fayolle J; Caballero M; Carabaña J; Celma ML; Fernandez-Muñoz R; Wild TF; Buckland R
J Virol; 1996 Jul; 70(7):4200-4. PubMed ID: 8676439
[TBL] [Abstract][Full Text] [Related]
13. Analysis of receptor (CD46, CD150) usage by measles virus.
Erlenhöfer C; Duprex WP; Rima BK; Ter Meulen V; Schneider-Schaulies J
J Gen Virol; 2002 Jun; 83(Pt 6):1431-1436. PubMed ID: 12029158
[TBL] [Abstract][Full Text] [Related]
14. Clinical isolates of measles virus use CD46 as a cellular receptor.
Manchester M; Eto DS; Valsamakis A; Liton PB; Fernandez-Muñoz R; Rota PA; Bellini WJ; Forthal DN; Oldstone MB
J Virol; 2000 May; 74(9):3967-74. PubMed ID: 10756008
[TBL] [Abstract][Full Text] [Related]
15. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.
Ono N; Tatsuo H; Hidaka Y; Aoki T; Minagawa H; Yanagi Y
J Virol; 2001 May; 75(9):4399-401. PubMed ID: 11287589
[TBL] [Abstract][Full Text] [Related]
16. Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake.
Firsching R; Buchholz CJ; Schneider U; Cattaneo R; ter Meulen V; Schneider-Schaulies J
J Virol; 1999 Jul; 73(7):5265-73. PubMed ID: 10364272
[TBL] [Abstract][Full Text] [Related]
17. A novel amino acid position in hemagglutinin glycoprotein of measles virus is responsible for hemadsorption and CD46 binding.
Li L; Qi Y
Arch Virol; 2002 Apr; 147(4):775-86. PubMed ID: 12038687
[TBL] [Abstract][Full Text] [Related]
18. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
Anderson BD; Nakamura T; Russell SJ; Peng KW
Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
[TBL] [Abstract][Full Text] [Related]
19. Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.
Vongpunsawad S; Oezgun N; Braun W; Cattaneo R
J Virol; 2004 Jan; 78(1):302-13. PubMed ID: 14671112
[TBL] [Abstract][Full Text] [Related]
20. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry.
Devaux P; Loveland B; Christiansen D; Milland J; Gerlier D
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1477-81. PubMed ID: 8757989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
